A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
for Primary Immune Thrombocytopenia (ITP)
18 locations incl. Phoenix
Sponsor: argenx
Sex: All·Age: 18+
Code: NCT06544499·Phase 3·Recruiting